Citations

Showing 10 of 108119 citations.

Improving ultrasonic evaluation of osteochondritis dissecans using a cadaveric model
Holmes, Philip M. , Chen, Kun-Hui , Lee, Hyungkyi, Leng, Shuai , Fitzsimmons, James S. , O’Driscoll, Shawn W. , Urban, Matthew W.

Mayo Clinic

The Journal of the Acoustical Society of America | November 18, 2021 | Volume: 150 | Issue: 4_Supplement | Pages: A88-A88

10.1121/10.0007720 Get It

Osteochondritis dissecans (OCD) is a joint disease that is prevalent among youth athletes. Medical ultrasound is currently limited in its ability to detect and monitor OCD due to limitations of current Delay-and-Sum (DAS) reconstruction algorithms. In this work, we used a Delay-Multiply-and-Sum (DMAS) reconstruction algorithm to improve medical ultrasound’s ability to diagnose OCD. We artificially generated OCD lesions in unfixed cadaveric elbows and imaged them with a research ultrasound machine. We also imaged these cadaveric limbs with x-ray computed tomography (CT) with a high-resolution acquisition. These CT images were used as a gold standard for OCD geometry. We reconstructed the ultrasound images using both DAS and DMAS algorithms and compared them quantitatively by taking several profiles across the images of the artificial OCD lesions. The image metrics that we measured within these profiles were OCD lesion contrast, bone interface clarity, and lesion crack thickness accuracy. We found that the DMAS algorithm improved OCD lesion contrast by up to 26% when compared to DAS. We also found that the DMAS algorithm reduced the variability of bone interface clarity overall. Future work will involve an in vivo study, as well as optimization, of the DMAS algorithm for OCD lesion imaging.
Answer to December 2021 Photo Quiz
Eberly, Allison R. , Natarjan, Usha, Milone, Amber A., Lucke, Marisa A., Cañete‐Gibas, Connie , Wiederhold, Nathan P. , Wengenack, Nancy L. , Eberly, Allison R , Wiederhold, Nathan

Mayo Clinic

Journal of Clinical Microbiology | November 18, 2021 | Volume: 59 | Issue: 12 | Pages: No page available

10.1128/jcm.02899-20 | PMID 34792389 Get It

Photo Quiz: You Get What You Get, and Sometimes It’s Tuberculate
Eberly, Allison R. , Natarjan, Usha, Milone, Amber A., Lucke, Marisa A., Cañete‐Gibas, Connie , Wiederhold, Nathan P. , Wengenack, Nancy L. , Eberly, Allison R , Wiederhold, Nathan

Mayo Clinic

Journal of Clinical Microbiology | November 18, 2021 | Volume: 59 | Issue: 12 | Pages: No page available

10.1128/jcm.02897-20 | PMID 34792388 Get It

Deep‐learning model observer for a low‐contrast hepatic metastases localization task in computed tomography
Gong, Hao , Heiken, Jay P. , Wells, Michael , Yu, Lifeng , Wells, Michael L, Fletcher, Joel G. , Leng, Shuai , McCollough, Cynthia H. , Yu, Lifeng

Mayo Clinic

Medical Physics | November 18, 2021 | Volume: 49 | Issue: 1 | Pages: 70-83

10.1002/mp.15362 | PMID 34792800 Get It

AbstractPurposeConventional model observers (MO) in CT are often limited to a uniform background or varying background that is random and can be modeled in an analytical form. It is unclear if these conventional MOs can be readily generalized to predict human observer performance in clinical CT tasks that involve realistic anatomical background. Deep‐learning‐based model observers (DL‐MO) have recently been developed, but have not been validated for challenging low contrast diagnostic tasks in abdominal CT. We consequently sought to validate a DL‐MO for a low‐contrast hepatic metastases localization task.MethodsWe adapted our recently developed DL‐MO framework for the liver metastases localization task. Our previously‐validated projection‐domain lesion‐/noise‐insertion techniques were used to synthesize realistic positive and low‐dose abdominal CT exams, using the archived patient projection data. Ten experimental conditions were generated, which involved different lesion sizes/contrasts, radiation dose levels, and image reconstruction types. Each condition included 100 trials generated from a patient cohort of 7 cases. Each trial was presented as liver image patches (160×160×5 voxels). The DL‐MO performance was calculated for each condition and was compared with human observer performance, which was obtained by three sub‐specialized radiologists in an observer study. The performance of DL‐MO and radiologists was gauged by the area under localization receiver‐operating‐characteristic curves. The generalization performance of the DL‐MO was estimated with the repeated twofold cross‐validation method over the same set of trials used in the human observer study. A multi‐slice Channelized Hoteling Observers (CHO) was compared with the DL‐MO across the same experimental conditions.ResultsThe performance of DL‐MO was highly correlated to that of radiologists (Pearson's correlation coefficient: 0.987; 95% CI: [0.942, 0.997]). The performance level of DL‐MO was comparable to that of the grouped radiologists, that is, the mean performance difference was ‐3.3%. The CHO performance was poorer than the grouped radiologist performance, before internal noise could be added. The correlation between CHO and radiologists was weaker (Pearson's correlation coefficient: 0.812, and 95% CI: [0.378, 0.955]), and the corresponding performance bias (‐29.5%) was statistically significant.ConclusionThe presented study demonstrated the potential of using the DL‐MO for image quality assessment in patient abdominal CT tasks.
Mechanical Thrombectomy of the Fetal Posterior Cerebral Artery
Abdalkader, Mohamad , Sahoo, Anurag , Brinjikji, Waleed , Dabus, Guilherme , Raz, Eytan , Laiso, Antonio , Maud, Alberto , Martínez‐Galdámez, Mario , Galván‐Fernández, Jorge , Schüller, Miguel , Khandelwal, Priyank , Zaidat, Osama O. , Martínez-Galdámez, Mario , Dmytriw, Adam A. , Dabus, Guilherme C. , Renieri, Leonardo , Al‐Mufti, Fawaz , Amuluru, Krishna , Fifi, Johanna T , Majidi, Shahram , Moore, Justin M. , Ortega-Gutierrez, Santiago , Hassan, Ameer E , Siegler, James E. , Nagel, Simon , Nguyen, Thanh N.

Mayo Clinic

Stroke: Vascular and Interventional Neurology | November 18, 2021 | Volume: 1 | Issue: 1 | Pages: No page available

10.1161/svin.121.000115 | PMID 41584460 Get It

Background Fetal posterior cerebral artery (FPCA) occlusion is a rare but potentially disabling cause of stroke. While endovascular treatment is established for acute large vessel occlusion stroke, FPCA occlusions were excluded from acute ischemic stroke trials. We aim to report the feasibility, safety, and outcome of mechanical thrombectomy in acute FPCA occlusions. Methods We performed a multicenter retrospective review of consecutive patients who underwent mechanical thrombectomy of acute FPCA occlusion. Primary FPCA occlusion was defined as an occlusion that was identified on the pre‐procedure computed tomography angiography or baseline angiogram whereas a secondary FPCA occlusion was defined as an occlusion that occurred secondary to embolization to a new territory after recanalization of a different large vessel occlusion. Demographics, clinical presentation, imaging findings, endovascular treatment, and outcome were reviewed. Results There were 25 patients with acute FPCA occlusion who underwent mechanical thrombectomy, distributed across 14 centers. Median National Institutes of Health Stroke Scale on presentation was 16. There were 76% (19/25) of patients who presented with primary FPCA occlusion and 24% (6/25) of patients who had a secondary FPCA occlusion. The configuration of the FPCA was full in 64% patients and partial or “fetal‐type” in 36% of patients. FPCA occlusion was missed on initial computed tomography angiography in 21% of patients with primary FPCA occlusion (4/19). The site of occlusion was posterior communicating artery in 52%, P2 segment in 40% and P3 in 8% of patients. Thrombolysis in cerebral infarction 2b/3 reperfusion was achieved in 96% of FPCA patients. There were no intraprocedural complications. At 90 days, 48% (12/25) were functionally independent as defined by modified Rankin scale≤2. Conclusions Endovascular treatment of acute FPCA occlusion is safe and technically feasible. A high index of suspicion is important to detect occlusion of the FPCA in patients presenting with anterior circulation stroke syndrome and patent anterior circulation. Novelty and significance This is the first multicenter study showing that thrombectomy of FPCA occlusion is feasible and safe.
The Role of Mesenchymal Stromal Cells in the Management of Knee Chondral Defects
Bush, Christopher J. , Grant, John A. , Krych, Aaron J. , Bedi, Asheesh , Krych, Aaron J , Grant, John A , Bush, Christopher J. , Bedi, Asheesh

Mayo Clinic

Journal of Bone and Joint Surgery | November 18, 2021 | Volume: 104 | Issue: 3 | Pages: 284-292

10.2106/jbjs.20.01800 | PMID 34793369 Get It

➤ Mesenchymal stromal cells (MSCs) are a subset of progenitor cells that help to promote tissue healing and regeneration through the secretion of various cytokines and growth factors. Although technically pluripotent, MSCs in vivo rarely repair damaged tissue through direct differentiation and engraftment. ➤ Augmentation of traditional marrow stimulation techniques with MSCs has been theorized to improve repair tissue quality and defect fill. Clinical trials evaluating this technique are limited but have shown modest improvements compared with isolated marrow stimulation. ➤ Various scaffolds also have been utilized in combination with MSCs to treat focal chondral defects. Although the techniques described are heterogeneous, many have shown promising early clinical outcomes. ➤ Newer techniques involving 3-dimensional bioprinted scaffolds seeded with MSCs allow for the recreation of complex architecture, more closely resembling articular cartilage. These techniques are evolving and have not yet been studied in human clinical trials.
Bloodstream Infection Following Cardiac Valve Repair: A Population-Based Study
McHugh, Jack , Talha, Khawaja M. , Arghami, Arman , DeSimone, Daniel C. , McHugh, Jack , Arghami, Arman , DeSimone, Daniel C , Baddour, Larry M. , Fischer, Karen M. , Crestanello, Juan A.

Mayo Clinic

Open Forum Infectious Diseases | November 18, 2021 | Volume: 8 | Issue: 11 | Pages: No page available

10.1093/ofid/ofab493 | PMID 34938821 Get It

Abstract Background The aim of this study was to determine the incidence, epidemiology, and associated risk factors of bloodstream infection (BSI) in patients who had previously undergone cardiac valve repair. Methods A population-based study that included 7 counties in southeastern Minnesota using the expanded Rochester Epidemiology Project (e-REP) for adults (≥18 years) who underwent valve repair between 1 January 2010 and 31 December 2018 was conducted. Electronic health records were screened for development of BSI and infective endocarditis (IE) from the date of valve repair through 30 July 2020. A 1:4 nested case-control analysis was performed to determine an association, if any, of male sex, Charlson comorbidity index (CCI), and county of residence with BSI. Results A total of 335 patients underwent valve repair, of whom 28 (8.3%) developed an index case of BSI, with 14 episodes occurring within 1 year of surgery. The median age of patients with BSI was 70 years, and 79% were male. The crude incidence of BSI was 1671 cases per 100000 person-years and Escherichia coli was the most common pathogen. Case-control analysis demonstrated a significant correlation between CCI and incidence of BSI (P < .001). Only 4 (14.3%) patients developed IE concurrent with the onset of BSI, and no patients developed IE subsequent to BSI. Conclusions The crude incidence of BSI following valve repair was higher in our e-REP cohort than previous population-based studies, and half of the BSI cases occurred within 1 year of surgery. Patients with a higher CCI at baseline were at increased risk of subsequent BSI.
Serum Biomarkers of Disease Activity in Longitudinal Assessment of Patients with ANCA‐Associated Vasculitis
Warner, Roscoe L., Tómasson, Gunnar , Stone, John H. , Hoffman, Gary S., Kallenberg, Cees G. M., Langford, Carol A. , Clair, E. William St. , Johnson, Kent J., Monach, Paul A , Monach, Paul A. , Lew, Robert , Specks, Ulrich , Fervenza, Fernando C. , Seo, Philip , Spiera, Robert , Merkel, Peter A.

Mayo Clinic

ACR Open Rheumatology | November 18, 2021 | Volume: 4 | Issue: 2 | Pages: 168-176

10.1002/acr2.11366 | PMID 34792864 Get It

ObjectiveImproved biomarkers of current disease activity and prediction of relapse are needed in antineutrophil cytoplasmic antibody–associated vasculitis (AAV). For clinical relevance, biomarkers must perform well longitudinally in patients on treatment and in patients with nonsevere flares.MethodsTwenty‐two proteins were measured in 347 serum samples from 74 patients with AAV enrolled in a clinical trial. Samples were collected at Month 6 after remission induction, then every 3 months until Month 18, or at the time of flare. Associations of protein concentrations with concurrent disease activity and with future flare were analyzed using mixed‐effects models, Cox proportional hazards models, and conditional logistic regression.ResultsForty‐two patients had flares during the 12‐month follow‐up period, and 32 remained in remission. Twenty‐two patients had severe flares. Six experimental markers (CXCL13, IL‐6, IL‐8, IL‐15, IL‐18BP, and matrix metalloproteinase‐3 [MMP‐3]) and ESR were associated with disease activity using all three methods (P < 0.05, with P < 0.01 in at least one method). A rise in IL‐8, IL‐15, or IL‐18BP was associated temporally with flare. Combining C‐reactive protein (CRP), IL‐18BP, neutrophil gelatinase‐associated lipocalin (NGAL), and sIL‐2Rα improved association with active AAV. CXCL13 and MMP‐3 were increased during treatment with prednisone, independent of disease activity. Marker concentrations during remission were not predictive of future flare.ConclusionSerum biomarkers of inflammation and tissue damage and repair have been previously shown to be strongly associated with severe active AAV were less strongly associated with active AAV in a longitudinal study that included mild flares and varying treatment. Markers rising contemporaneously with flare or with an improved association in combination merit further study.
Are Baseball Statistics an Appropriate Tool for Assessing Return to Play in Injured Pitchers? Analysis of Statistical Variability in Healthy Players
Pareek, Ayoosh , Parkes, Chad W. , Leontovich, Alexey A. , Krych, Aaron J. , Conte, Stan, Steubs, John A. , Wulf, Corey A., Krych, Aaron J , Camp, Christopher L.

Mayo Clinic

Orthopaedic Journal of Sports Medicine | November 18, 2021 | Volume: 9 | Issue: 11 | Pages: No page available

10.1177/23259671211050933 | PMID 34820461 Get It

Background: Basic pitcher statistics have been used to assess performance in pitchers after injury or surgery without being validated. Even among healthy pitchers, the normal variability of these parameters has not yet been established. Purpose: To determine (1) the normal variability of basic and advanced pitcher statistics in healthy professional baseball pitchers and (2) the minimum pitches needed to predict these parameters. Study Design: Cross-sectional study; Level of evidence, 3. Methods: Publicly available data from the MLB Statcast and PITCHf/x databases were used to analyze MLB pitchers during the 2015 and 2016 seasons who recorded a minimum of 100 innings without injury. Basic and advanced baseball pitcher statistics were analyzed. The variability of each parameter was assessed by computing the coefficient of variation (CV) between individual pitchers and across all pitchers. A CV <10 was indicative of a relatively constant parameter, and parameters with a CV >10 were generally considered inconsistent and unreliable. The minimum number of pitches needed to be followed for each variable was also analyzed. Results: A total of 118 pitchers, 55 baseball-specific statistical metrics (38 basic and 17 advanced), and 7.5 million pitches were included and analyzed. Of the 38 basic pitcher statistics, only fastball velocity demonstrated a CV <10 (CV = 1.5), while 6 of 17 (35%) advanced metrics demonstrated acceptable consistency (CV <10). Release position from plate and velocity from the plate were the 2 most consistent advanced parameters. When separated by pitch type, these 2 parameters were the most constant (lowest CV) across every pitch type. Conclusion: We recommend against utilizing nonvalidated statistical measures to assess performance after injury, as they demonstrated unacceptably high variability even among healthy, noninjured professional baseball pitchers. It is our hope that this study will serve as the foundation for the identification and implementation of validated pitcher-dependent statistical measures that can be used to assess return-to-play performance after injury in the future.